164 related articles for article (PubMed ID: 31531762)
1. Intensive weight gain therapy in patients with anorexia nervosa results in improved serum tartrate-resistant acid phosphatase (TRAP) 5a and 5b isoform protein levels.
Patlaka C; Tubic B; Lång P; Paulie S; Swolin-Eide D; Magnusson P; Andersson G
Eat Weight Disord; 2020 Oct; 25(5):1387-1397. PubMed ID: 31531762
[TBL] [Abstract][Full Text] [Related]
2. A Novel Sandwich ELISA for Tartrate-Resistant Acid Phosphatase 5a and 5b Protein Reveals that Both Isoforms are Secreted by Differentiating Osteoclasts and Correlate to the Type I Collagen Degradation Marker CTX-I In Vivo and In Vitro.
Mira-Pascual L; Patlaka C; Desai S; Paulie S; Näreoja T; Lång P; Andersson G
Calcif Tissue Int; 2020 Feb; 106(2):194-207. PubMed ID: 31654098
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of tartrate-resistant acid phosphatase isoforms 5a and 5b by tumor and stromal cells in human metastatic bone disease.
Zenger S; He W; Ek-Rylander B; Vassiliou D; Wedin R; Bauer H; Andersson G
Clin Exp Metastasis; 2011 Jan; 28(1):65-73. PubMed ID: 20967488
[TBL] [Abstract][Full Text] [Related]
4. Naphthol-ASBI phosphate as a preferred substrate for tartrate-resistant acid phosphatase isoform 5b.
Janckila AJ; Takahashi K; Sun SZ; Yam LT
J Bone Miner Res; 2001 Apr; 16(4):788-93. PubMed ID: 11316008
[TBL] [Abstract][Full Text] [Related]
5. The adipokine tartrate-resistant acid phosphatase 5a in serum correlates to adipose tissue expansion in obesity.
Patlaka C; Mira Pascual L; Paulie S; Henriksson AF; Arner P; Lång P; Andersson G
Biomarkers; 2017 Dec; 22(8):764-774. PubMed ID: 28532220
[TBL] [Abstract][Full Text] [Related]
6. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption.
Halleen JM; Alatalo SL; Suominen H; Cheng S; Janckila AJ; Väänänen HK
J Bone Miner Res; 2000 Jul; 15(7):1337-45. PubMed ID: 10893682
[TBL] [Abstract][Full Text] [Related]
7. Biogenesis of tartrate-resistant acid phosphatase isoforms 5a and 5b in stably transfected MDA-MB-231 breast cancer epithelial cells.
Zenger S; Ek-Rylander B; Andersson G
Biochim Biophys Acta; 2010 May; 1803(5):598-607. PubMed ID: 20149826
[TBL] [Abstract][Full Text] [Related]
8. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
[TBL] [Abstract][Full Text] [Related]
9. Electrophoretic study of tartrate-resistant acid phosphatase isoforms in endstage renal disease and rheumatoid arthritis.
Takahashi K; Janckila AJ; Sun SZ; Lederer ED; Ray PC; Yam LT
Clin Chim Acta; 2000 Nov; 301(1-2):147-58. PubMed ID: 11020469
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin K regulates localization and secretion of Tartrate-Resistant Acid Phosphatase (TRAP) in TRAP-overexpressing MDA-MB-231 breast cancer cells.
Reithmeier A; Norgård M; Ek-Rylander B; Näreoja T; Andersson G
BMC Mol Cell Biol; 2020 Mar; 21(1):15. PubMed ID: 32188406
[TBL] [Abstract][Full Text] [Related]
11. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
Janckila AJ; Takahashi K; Sun SZ; Yam LT
Clin Chem; 2001 Jan; 47(1):74-80. PubMed ID: 11148180
[TBL] [Abstract][Full Text] [Related]
12. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
Halleen JM; Ylipahkala H; Alatalo SL; Janckila AJ; Heikkinen JE; Suominen H; Cheng S; Väänänen HK
Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156
[TBL] [Abstract][Full Text] [Related]
13. The small chemical enzyme inhibitor 5-phenylnicotinic acid/CD13 inhibits cell migration and invasion of tartrate-resistant acid phosphatase/ACP5-overexpressing MDA-MB-231 breast cancer cells.
Krumpel M; Reithmeier A; Senge T; Baeumler TA; Frank M; Nyholm PG; Ek-Rylander B; Andersson G
Exp Cell Res; 2015 Nov; 339(1):154-62. PubMed ID: 26428664
[TBL] [Abstract][Full Text] [Related]
14. Suitability of tartrate-resistant acid phosphatase type 5b as a screening marker for bone mineral density in community-dwelling elderly individuals.
Irie S; Hayashida N; Shinkawa T; Taira Y; Sekitani Y; Teraoka S; Hashiguchi K; Yoshida K; Morishita M; Takamura N
Tohoku J Exp Med; 2011 Jun; 224(2):105-10. PubMed ID: 21597244
[TBL] [Abstract][Full Text] [Related]
15. Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells.
Janckila AJ; Parthasarathy RN; Parthasarathy LK; Seelan RS; Hsueh YC; Rissanen J; Alatalo SL; Halleen JM; Yam LT
J Leukoc Biol; 2005 Feb; 77(2):209-18. PubMed ID: 15542543
[TBL] [Abstract][Full Text] [Related]
16. Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.
Chao TY; Lee SH; Chen MM; Neustadt DH; Chaudhry UA; Yam LT; Janckila AJ
Clin Chim Acta; 2005 Sep; 359(1-2):132-40. PubMed ID: 15993395
[TBL] [Abstract][Full Text] [Related]
17. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
[TBL] [Abstract][Full Text] [Related]
18. Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
Janckila AJ; Yam LT
Calcif Tissue Int; 2009 Dec; 85(6):465-83. PubMed ID: 19915788
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
Capeller B; Caffier H; Sütterlin MW; Dietl J
Anticancer Res; 2003; 23(2A):1011-5. PubMed ID: 12820340
[TBL] [Abstract][Full Text] [Related]
20. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].
Nowak Z; Konieczna M; Wańkowicz Z
Pol Merkur Lekarski; 2004 Aug; 17(98):138-41. PubMed ID: 15603322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
